Drug information for PENTAMIDINE ISETHIONATE
Form
Dosage
Status
Therapeutic Equivalence
Active Ingred
Ref.
Sponsor
Document
INJECTABLE; INJECTION
300MG/VIAL
Discontinued
PENTAMIDINE ISETHIONATE
Pentamidine
HOSPIRA
73479
2007-07-09 Review
INJECTABLE; INJECTION
300MG/VIAL
Discontinued
PENTAMIDINE ISETHIONATE
Pentamidine
BAXTER HLTHCARE
73617
INJECTABLE; INJECTION
300MG/VIAL
Prescription
AP
PENTAMIDINE ISETHIONATE
Pentamidine
WATSON LABS
74303
Drug Adverse Effects information for PENTAMIDINE ISETHIONATE
Role code
Indications
Reaction
# Reports
PS
IMMUNOSUPPRESSION
DRUG INTERACTION
3
PS
IMMUNOSUPPRESSION
LIPIDS INCREASED
3
PS
PNEUMOCYSTIS JIROVECI PNEUMONIA
DRUG INTERACTION
1
PS
PNEUMOCYSTIS JIROVECI PNEUMONIA
LIPIDS INCREASED
1
PS
PNEUMONIA
ALVEOLITIS
1
PS
PNEUMONIA
BLOOD PRESSURE INCREASED
1
PS
PNEUMONIA
BRONCHIECTASIS
1
PS
PNEUMONIA
CONFUSIONAL STATE
1
PS
PNEUMONIA
CONVULSION
1
PS
PNEUMONIA
DIFFUSE ALVEOLAR DAMAGE
1
PS
PNEUMONIA
DRUG INTERACTION
5
PS
PNEUMONIA
FIBROSIS
1
PS
PNEUMONIA
GRANULOMA
1
PS
PNEUMONIA
HAEMODIALYSIS
1
PS
PNEUMONIA
HYPERKALAEMIA
1
PS
PNEUMONIA
KIDNEY FIBROSIS
1
PS
PNEUMONIA
LIPIDS INCREASED
6
PS
PNEUMONIA
OBLITERATIVE BRONCHIOLITIS
1
PS
PNEUMONIA
ORGANISING PNEUMONIA
1
PS
PNEUMONIA
PLATELET COUNT DECREASED
1
PS
PNEUMONIA
PNEUMONIA ASPIRATION
1
PS
PNEUMONIA
PNEUMONITIS
1
PS
PNEUMONIA
POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME
1
PS
PNEUMONIA
POTENTIATING DRUG INTERACTION
1
PS
PNEUMONIA
PULMONARY FIBROSIS
1
PS
PNEUMONIA
PULMONARY TOXICITY
1
PS
PNEUMONIA
RENAL FAILURE
1
PS
PNEUMONIA
RENAL TUBULAR ATROPHY
1
PS
PNEUMONIA
RESPIRATORY DISTRESS
1
PS
PNEUMONIA
THROMBOTIC MICROANGIOPATHY
1
PS
PNEUMONIA
TOXICITY TO VARIOUS AGENTS
1
PS
PNEUMONIA
VISUAL ACUITY REDUCED
1
PS
PRODUCT USED FOR UNKNOWN INDICATION
DRUG INTERACTION
9
PS
PRODUCT USED FOR UNKNOWN INDICATION
LIPIDS INCREASED
9
SS
IMMUNOSUPPRESSION
DRUG INTERACTION
3
SS
IMMUNOSUPPRESSION
LIPIDS INCREASED
3
SS
PNEUMOCYSTIS JIROVECI PNEUMONIA
DRUG INTERACTION
1
SS
PNEUMOCYSTIS JIROVECI PNEUMONIA
LIPIDS INCREASED
1
SS
PNEUMONIA
DRUG INTERACTION
5
SS
PNEUMONIA
LIPIDS INCREASED
5
SS
PRODUCT USED FOR UNKNOWN INDICATION
DRUG INTERACTION
9
SS
PRODUCT USED FOR UNKNOWN INDICATION
LIPIDS INCREASED
9
C
APLASTIC ANAEMIA
ASPERGILLOSIS
2
C
APLASTIC ANAEMIA
BACTERIAL INFECTION
2
C
APLASTIC ANAEMIA
CANDIDIASIS
2
C
APLASTIC ANAEMIA
CHRONIC GRAFT VERSUS HOST DISEASE
2
C
APLASTIC ANAEMIA
CYTOMEGALOVIRUS INFECTION
2
C
APLASTIC ANAEMIA
LIVER DISORDER
2
C
APLASTIC ANAEMIA
PYREXIA
2
C
APLASTIC ANAEMIA
VIRAL INFECTION
2
C
ASPERGILLOSIS
ASPERGILLOSIS
7
C
ASPERGILLOSIS
BACTERIAL INFECTION
7
C
ASPERGILLOSIS
CANDIDIASIS
7
C
ASPERGILLOSIS
CHRONIC GRAFT VERSUS HOST DISEASE
7
C
ASPERGILLOSIS
CYTOMEGALOVIRUS INFECTION
7
C
ASPERGILLOSIS
LIVER DISORDER
7
C
ASPERGILLOSIS
PYREXIA
7
C
ASPERGILLOSIS
VIRAL INFECTION
7
C
BONE MARROW CONDITIONING REGIMEN
ASPERGILLOSIS
1
C
BONE MARROW CONDITIONING REGIMEN
BACTERIAL INFECTION
1
C
BONE MARROW CONDITIONING REGIMEN
CANDIDIASIS
1
C
BONE MARROW CONDITIONING REGIMEN
CHRONIC GRAFT VERSUS HOST DISEASE
1
C
BONE MARROW CONDITIONING REGIMEN
CYTOMEGALOVIRUS INFECTION
1
C
BONE MARROW CONDITIONING REGIMEN
LIVER DISORDER
1
C
BONE MARROW CONDITIONING REGIMEN
PYREXIA
1
C
BONE MARROW CONDITIONING REGIMEN
VIRAL INFECTION
1
C
CANDIDIASIS
ASPERGILLOSIS
7
C
CANDIDIASIS
BACTERIAL INFECTION
7
C
CANDIDIASIS
CANDIDIASIS
7
C
CANDIDIASIS
CHRONIC GRAFT VERSUS HOST DISEASE
7
C
CANDIDIASIS
CYTOMEGALOVIRUS INFECTION
7
C
CANDIDIASIS
LIVER DISORDER
7
C
CANDIDIASIS
PYREXIA
7
C
CANDIDIASIS
VIRAL INFECTION
7
C
CYTOMEGALOVIRUS CHORIORETINITIS
BLOOD ALKALINE PHOSPHATASE INCREASED
2
C
CYTOMEGALOVIRUS CHORIORETINITIS
BRONCHOPULMONARY ASPERGILLOSIS
2
C
CYTOMEGALOVIRUS CHORIORETINITIS
CYTOMEGALOVIRUS CHORIORETINITIS
2
C
CYTOMEGALOVIRUS CHORIORETINITIS
GAMMA-GLUTAMYLTRANSFERASE INCREASED
2
C
CYTOMEGALOVIRUS CHORIORETINITIS
LYMPHOMA
2
C
CYTOMEGALOVIRUS CHORIORETINITIS
PLATELET COUNT DECREASED
2
C
DIABETES MELLITUS
BACK PAIN
2
C
DIABETES MELLITUS
CALCULUS URETERIC
2
C
DIABETES MELLITUS
CHILLS
2
C
DIABETES MELLITUS
FEELING HOT
2
C
DIABETES MELLITUS
PYELONEPHRITIS ACUTE
2
C
DIABETES MELLITUS
PYURIA
2
C
HEART TRANSPLANT REJECTION
EPILEPSY
1
C
HEART TRANSPLANT REJECTION
GRANULOCYTOPENIA
1
C
HEART TRANSPLANT REJECTION
HAEMOGLOBIN DECREASED
1
C
HEART TRANSPLANT REJECTION
STAPHYLOCOCCAL INFECTION
1
C
HEART TRANSPLANT REJECTION
UTERINE LEIOMYOMA
1
C
HEART TRANSPLANT REJECTION
WHITE BLOOD CELL COUNT DECREASED
1
C
HIV INFECTION
AGGRESSION
1
C
HIV INFECTION
AGITATION
1
C
HIV INFECTION
ALOPECIA
1
C
HIV INFECTION
ANAEMIA HAEMOLYTIC AUTOIMMUNE
1
C
HIV INFECTION
ARTHRALGIA
1
C
HIV INFECTION
ATELECTASIS
1
C
HIV INFECTION
BACK PAIN
8
C
HIV INFECTION
BLOOD ALBUMIN DECREASED
1
C
HIV INFECTION
BLOOD ALKALINE PHOSPHATASE INCREASED
12
C
HIV INFECTION
BLOOD BILIRUBIN INCREASED
8
C
HIV INFECTION
BRONCHIECTASIS
1
C
HIV INFECTION
BRONCHOPULMONARY ASPERGILLOSIS
12
C
HIV INFECTION
C-REACTIVE PROTEIN INCREASED
8
C
HIV INFECTION
CALCULUS URETERIC
8
C
HIV INFECTION
CHILLS
8
C
HIV INFECTION
CYANOSIS
1
C
HIV INFECTION
CYTOMEGALOVIRUS CHORIORETINITIS
12
C
HIV INFECTION
DEAFNESS
1
C
HIV INFECTION
DEHYDRATION
1
C
HIV INFECTION
DEPRESSION
1
C
HIV INFECTION
DIABETIC KETOACIDOSIS
1
C
HIV INFECTION
DIARRHOEA
1
C
HIV INFECTION
DISEASE RECURRENCE
1
C
HIV INFECTION
EAR DISORDER
1
C
HIV INFECTION
EAR INFECTION
1
C
HIV INFECTION
ELECTROCARDIOGRAM QT PROLONGED
1
C
HIV INFECTION
ELECTROLYTE IMBALANCE
1
C
HIV INFECTION
ENCEPHALOPATHY
1
C
HIV INFECTION
EXFOLIATIVE RASH
1
C
HIV INFECTION
FACE OEDEMA
1
C
HIV INFECTION
FEELING HOT
8
C
HIV INFECTION
FLUID OVERLOAD
1
C
HIV INFECTION
FUNGAEMIA
1
C
HIV INFECTION
GAMMA-GLUTAMYLTRANSFERASE INCREASED
12
C
HIV INFECTION
HAEMOLYTIC URAEMIC SYNDROME
1
C
HIV INFECTION
HEPATIC STEATOSIS
1
C
HIV INFECTION
HERPES ZOSTER
1
C
HIV INFECTION
HYPOKALAEMIA
1
C
HIV INFECTION
HYPONATRAEMIA
1
C
HIV INFECTION
INDURATION
1
C
HIV INFECTION
JAUNDICE
8
C
HIV INFECTION
LETHARGY
1
C
HIV INFECTION
LYMPHOMA
12
C
HIV INFECTION
METABOLIC ACIDOSIS
1
C
HIV INFECTION
METAPNEUMOVIRUS INFECTION
1
C
HIV INFECTION
MYALGIA
1
C
HIV INFECTION
NYSTAGMUS
1
C
HIV INFECTION
OCULAR HYPERAEMIA
1
C
HIV INFECTION
OPPORTUNISTIC INFECTION
1
C
HIV INFECTION
OXYGEN SATURATION DECREASED
8
C
HIV INFECTION
PAIN
1
C
HIV INFECTION
PANCREATITIS
1
C
HIV INFECTION
PLATELET COUNT DECREASED
12
C
HIV INFECTION
PLEURAL EFFUSION
9
C
HIV INFECTION
PNEUMONIA
9
C
HIV INFECTION
PYELONEPHRITIS ACUTE
8
C
HIV INFECTION
PYURIA
8
C
HIV INFECTION
RASH ERYTHEMATOUS
1
C
HIV INFECTION
RASH GENERALISED
1
C
HIV INFECTION
RASH MACULO-PAPULAR
1
C
HIV INFECTION
RASH PRURITIC
1
C
HIV INFECTION
RENAL FAILURE ACUTE
1
C
HIV INFECTION
RESPIRATORY RATE INCREASED
1
C
HIV INFECTION
RHINOVIRUS INFECTION
1
C
HIV INFECTION
SEPSIS
1
C
HIV INFECTION
SUICIDAL IDEATION
1
C
HIV INFECTION
SWELLING
1
C
HIV INFECTION
TACHYCARDIA
1
C
HIV INFECTION
TACHYPNOEA
1
C
HIV INFECTION
THROMBOCYTOPENIA
1
C
HIV INFECTION
THROMBOTIC THROMBOCYTOPENIC PURPURA
1
C
HIV INFECTION
TOOTHACHE
1
C
HIV INFECTION
TOXICITY TO VARIOUS AGENTS
1
C
HIV INFECTION
TREATMENT NONCOMPLIANCE
1
C
HIV INFECTION
TREMOR
1
C
HIV INFECTION
TYPE 2 DIABETES MELLITUS
1
C
HIV INFECTION
WHITE BLOOD CELL COUNT INCREASED
8
C
HYPERURICAEMIA
BLOOD BILIRUBIN INCREASED
2
C
HYPERURICAEMIA
C-REACTIVE PROTEIN INCREASED
2
C
HYPERURICAEMIA
JAUNDICE
2
C
HYPERURICAEMIA
OXYGEN SATURATION DECREASED
2
C
HYPERURICAEMIA
PLEURAL EFFUSION
2
C
HYPERURICAEMIA
PNEUMONIA
2
C
HYPERURICAEMIA
WHITE BLOOD CELL COUNT INCREASED
2
C
INFECTION PROPHYLAXIS
ASPERGILLOSIS
14
C
INFECTION PROPHYLAXIS
BACTERIAL INFECTION
14
C
INFECTION PROPHYLAXIS
CANDIDIASIS
14
C
INFECTION PROPHYLAXIS
CHRONIC GRAFT VERSUS HOST DISEASE
14
C
INFECTION PROPHYLAXIS
CYTOMEGALOVIRUS INFECTION
14
C
INFECTION PROPHYLAXIS
LIVER DISORDER
14
C
INFECTION PROPHYLAXIS
PYREXIA
14
C
INFECTION PROPHYLAXIS
VIRAL INFECTION
14
C
LIVER DISORDER
ASPERGILLOSIS
3
C
LIVER DISORDER
BACTERIAL INFECTION
3
C
LIVER DISORDER
CANDIDIASIS
3
C
LIVER DISORDER
CHRONIC GRAFT VERSUS HOST DISEASE
3
C
LIVER DISORDER
CYTOMEGALOVIRUS INFECTION
3
C
LIVER DISORDER
LIVER DISORDER
3
C
LIVER DISORDER
PYREXIA
3
C
LIVER DISORDER
VIRAL INFECTION
3
C
MENINGITIS
ASPERGILLOSIS
7
C
MENINGITIS
BACTERIAL INFECTION
7
C
MENINGITIS
CANDIDIASIS
7
C
MENINGITIS
CHRONIC GRAFT VERSUS HOST DISEASE
7
C
MENINGITIS
CYTOMEGALOVIRUS INFECTION
7
C
MENINGITIS
LIVER DISORDER
7
C
MENINGITIS
PYREXIA
7
C
MENINGITIS
VIRAL INFECTION
7
C
MYCOBACTERIUM AVIUM COMPLEX INFECTION
BACK PAIN
6
C
MYCOBACTERIUM AVIUM COMPLEX INFECTION
CALCULUS URETERIC
6
C
MYCOBACTERIUM AVIUM COMPLEX INFECTION
CHILLS
6
C
MYCOBACTERIUM AVIUM COMPLEX INFECTION
FEELING HOT
6
C
MYCOBACTERIUM AVIUM COMPLEX INFECTION
PYELONEPHRITIS ACUTE
6
C
MYCOBACTERIUM AVIUM COMPLEX INFECTION
PYURIA
6
C
OPPORTUNISTIC INFECTION PROPHYLAXIS
BLOOD ALKALINE PHOSPHATASE INCREASED
2
C
OPPORTUNISTIC INFECTION PROPHYLAXIS
BRONCHOPULMONARY ASPERGILLOSIS
2
C
OPPORTUNISTIC INFECTION PROPHYLAXIS
CYTOMEGALOVIRUS CHORIORETINITIS
2
C
OPPORTUNISTIC INFECTION PROPHYLAXIS
GAMMA-GLUTAMYLTRANSFERASE INCREASED
2
C
OPPORTUNISTIC INFECTION PROPHYLAXIS
LYMPHOMA
2
C
OPPORTUNISTIC INFECTION PROPHYLAXIS
PLATELET COUNT DECREASED
2
C
ORAL CANDIDIASIS
BLOOD BILIRUBIN INCREASED
2
C
ORAL CANDIDIASIS
C-REACTIVE PROTEIN INCREASED
2
C
ORAL CANDIDIASIS
JAUNDICE
2
C
ORAL CANDIDIASIS
OXYGEN SATURATION DECREASED
2
C
ORAL CANDIDIASIS
PLEURAL EFFUSION
2
C
ORAL CANDIDIASIS
PNEUMONIA
2
C
ORAL CANDIDIASIS
WHITE BLOOD CELL COUNT INCREASED
2
C
PNEUMOCYSTIS JIROVECI PNEUMONIA
BACK PAIN
2
C
PNEUMOCYSTIS JIROVECI PNEUMONIA
BLOOD BILIRUBIN INCREASED
2
C
PNEUMOCYSTIS JIROVECI PNEUMONIA
C-REACTIVE PROTEIN INCREASED
2
C
PNEUMOCYSTIS JIROVECI PNEUMONIA
CALCULUS URETERIC
2
C
PNEUMOCYSTIS JIROVECI PNEUMONIA
CHILLS
2
C
PNEUMOCYSTIS JIROVECI PNEUMONIA
FEELING HOT
2
C
PNEUMOCYSTIS JIROVECI PNEUMONIA
JAUNDICE
2
C
PNEUMOCYSTIS JIROVECI PNEUMONIA
OXYGEN SATURATION DECREASED
2
C
PNEUMOCYSTIS JIROVECI PNEUMONIA
PLEURAL EFFUSION
2
C
PNEUMOCYSTIS JIROVECI PNEUMONIA
PNEUMONIA
2
C
PNEUMOCYSTIS JIROVECI PNEUMONIA
PYELONEPHRITIS ACUTE
2
C
PNEUMOCYSTIS JIROVECI PNEUMONIA
PYURIA
2
C
PNEUMOCYSTIS JIROVECI PNEUMONIA
WHITE BLOOD CELL COUNT INCREASED
2
C
PREMEDICATION
ASPERGILLOSIS
4
C
PREMEDICATION
BACTERIAL INFECTION
4
C
PREMEDICATION
CANDIDIASIS
4
C
PREMEDICATION
CHRONIC GRAFT VERSUS HOST DISEASE
4
C
PREMEDICATION
CYTOMEGALOVIRUS INFECTION
4
C
PREMEDICATION
LIVER DISORDER
4
C
PREMEDICATION
PYREXIA
4
C
PREMEDICATION
VIRAL INFECTION
4
C
PRODUCT USED FOR UNKNOWN INDICATION
BLOOD BILIRUBIN INCREASED
2
C
PRODUCT USED FOR UNKNOWN INDICATION
C-REACTIVE PROTEIN INCREASED
2
C
PRODUCT USED FOR UNKNOWN INDICATION
JAUNDICE
2
C
PRODUCT USED FOR UNKNOWN INDICATION
OXYGEN SATURATION DECREASED
2
C
PRODUCT USED FOR UNKNOWN INDICATION
PLEURAL EFFUSION
2
C
PRODUCT USED FOR UNKNOWN INDICATION
PNEUMONIA
2
C
PRODUCT USED FOR UNKNOWN INDICATION
WHITE BLOOD CELL COUNT INCREASED
2
C
PROPHYLAXIS
ASPERGILLOSIS
8
C
PROPHYLAXIS
BACK PAIN
2
C
PROPHYLAXIS
BACTERIAL INFECTION
8
C
PROPHYLAXIS
BLOOD BILIRUBIN INCREASED
2
C
PROPHYLAXIS
C-REACTIVE PROTEIN INCREASED
2
C
PROPHYLAXIS
CALCULUS URETERIC
2
C
PROPHYLAXIS
CANDIDIASIS
8
C
PROPHYLAXIS
CHILLS
2
C
PROPHYLAXIS
CHRONIC GRAFT VERSUS HOST DISEASE
8
C
PROPHYLAXIS
CYTOMEGALOVIRUS INFECTION
8
C
PROPHYLAXIS
EPILEPSY
15
C
PROPHYLAXIS
FEELING HOT
2
C
PROPHYLAXIS
GRANULOCYTOPENIA
15
C
PROPHYLAXIS
HAEMOGLOBIN DECREASED
15
C
PROPHYLAXIS
JAUNDICE
2
C
PROPHYLAXIS
LIVER DISORDER
8
C
PROPHYLAXIS
OXYGEN SATURATION DECREASED
2
C
PROPHYLAXIS
PLEURAL EFFUSION
2
C
PROPHYLAXIS
PNEUMONIA
2
C
PROPHYLAXIS
PYELONEPHRITIS ACUTE
2
C
PROPHYLAXIS
PYREXIA
8
C
PROPHYLAXIS
PYURIA
2
C
PROPHYLAXIS
STAPHYLOCOCCAL INFECTION
15
C
PROPHYLAXIS
UTERINE LEIOMYOMA
15
C
PROPHYLAXIS
VIRAL INFECTION
8
C
PROPHYLAXIS
WHITE BLOOD CELL COUNT DECREASED
15
C
PROPHYLAXIS
WHITE BLOOD CELL COUNT INCREASED
2
C
PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE
ASPERGILLOSIS
5
C
PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE
BACTERIAL INFECTION
5
C
PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE
CANDIDIASIS
5
C
PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE
CHRONIC GRAFT VERSUS HOST DISEASE
5
C
PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE
CYTOMEGALOVIRUS INFECTION
5
C
PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE
LIVER DISORDER
5
C
PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE
PYREXIA
5
C
PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE
VIRAL INFECTION
5
C
PROPHYLAXIS AGAINST TRANSPLANT REJECTION
EPILEPSY
3
C
PROPHYLAXIS AGAINST TRANSPLANT REJECTION
GRANULOCYTOPENIA
3
C
PROPHYLAXIS AGAINST TRANSPLANT REJECTION
HAEMOGLOBIN DECREASED
3
C
PROPHYLAXIS AGAINST TRANSPLANT REJECTION
STAPHYLOCOCCAL INFECTION
3
C
PROPHYLAXIS AGAINST TRANSPLANT REJECTION
UTERINE LEIOMYOMA
3
C
PROPHYLAXIS AGAINST TRANSPLANT REJECTION
WHITE BLOOD CELL COUNT DECREASED
3
Ads by Google